VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
12652
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1518
Interactions with Platform & by Email
PARTICIPANTS
382
Unique # Participated
VALIDATIONS
172
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEPTEMBER 2020
TABLES
231
PAGES
308
EDITION
7
PRICE
USD $5450
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Cancer Diagnostics Market?
Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150.6 Billion in the year 2020, is projected to reach a revised size of US$223.3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period.
The Cancer Diagnostics market in the U.S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 308-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Diagnostics; Abbott Laboratories; Agilent Technologies, Inc.; Ambry Genetics Corporation; Applied Imaging; AstraZeneca PLC; AutoGenomics, Inc.; BARD, A Becton, Dickinson Company; Bayer AG; Becton, Dickinson and Company; BioCurex, Inc.; bioMeriux SA; Celara Diagnostics; Diagnostic Products Corporation; Eli Lilly and Company; F. Hoffmann-La Roche AG; GE Healthcare; Genoptix, Inc.; GlaxoSmithKline PLC; Hologic, Inc.; Illumina, Inc.; Pfizer, Inc.; Philips Healthcare; QIAGEN GmbH; Siemens Healthineers; Thermo Fisher Scientific, Inc.
» Application (Breast, Lung, Colorectal, Skin, Prostate, Blood, Ovarian, Other Applications) » Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Other Types)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Cancer Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cancer Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cancer Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Cancer Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Laboratory Tests (Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Laboratory Tests (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Laboratory Tests (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Genetic Tests (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Genetic Tests (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Genetic Tests (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Imaging (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Imaging (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Imaging (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Endoscopy (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Endoscopy (Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Endoscopy (Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Biopsy (Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Biopsy (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Biopsy (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Other Types (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Other Types (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Other Types (Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027 |
| Breast (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Breast (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Breast (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Lung (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Lung (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 |
| Lung (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| Colorectal (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 |
| Colorectal (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 |
| Colorectal (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Skin (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 |
| Skin (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Skin (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Prostate (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Prostate (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Prostate (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Blood (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Blood (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Blood (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Ovarian (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Ovarian (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Ovarian (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 |
| Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Cancer Diagnostics Market Share (in %) by Company: 2019 & 2025 |
| United States Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027 |
| Cancer Diagnostics Market in the United States by Type: A Historic Review in US$ Million for 2012-2019 |
| United States Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| United States Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 |
| Cancer Diagnostics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 |
| Canadian Cancer Diagnostics Historic Market Review by Type in US$ Million: 2012-2019 |
| Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 |
| Canadian Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Canadian Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 |
| Japanese Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Japanese Cancer Diagnostics Market in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Historic Market Analysis in China in US$ Million by Type: 2012-2019 |
| Chinese Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market Review in China in US$ Million by Application: 2012-2019 |
| Chinese Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Cancer Diagnostics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Cancer Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Cancer Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Cancer Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027 |
| Cancer Diagnostics Market in Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 |
| European Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| European Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| European Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| FRANCE |
| Cancer Diagnostics Market in France by Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019 |
| French Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 |
| French Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019 |
| French Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| GERMANY |
| Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| German Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| German Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| German Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Historic Market Analysis in Italy in US$ Million by Type: 2012-2019 |
| Italian Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market Review in Italy in US$ Million by Application: 2012-2019 |
| Italian Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 |
| United Kingdom Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| United Kingdom Cancer Diagnostics Market in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| SPAIN |
| Spanish Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 |
| Spanish Cancer Diagnostics Historic Market Review by Type in US$ Million: 2012-2019 |
| Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 |
| Spanish Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Spanish Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| RUSSIA |
| Russian Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027 |
| Cancer Diagnostics Market in Russia by Type: A Historic Review in US$ Million for 2012-2019 |
| Russian Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Russian Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019 |
| Cancer Diagnostics Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027 |
| Cancer Diagnostics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012-2019 |
| Rest of Europe Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Rest of Europe Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Rest of Europe Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cancer Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019 |
| Asia-Pacific Cancer Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019 |
| Asia-Pacific Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 |
| Asia-Pacific Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019 |
| Asia-Pacific Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| AUSTRALIA |
| Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| Australian Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| Australian Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Australian Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 |
| INDIA |
| Indian Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 |
| Indian Cancer Diagnostics Historic Market Review by Type in US$ Million: 2012-2019 |
| Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 |
| Indian Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Indian Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| SOUTH KOREA |
| Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| South Korean Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 |
| South Korean Cancer Diagnostics Historic Market Analysis in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 |
| Rest of Asia-Pacific Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Rest of Asia-Pacific Cancer Diagnostics Market in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 |
| LATIN AMERICA |
| Latin American Cancer Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027 |
| Cancer Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019 |
| Latin American Cancer Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 |
| Latin American Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Historic Market Analysis in Latin America in US$ Million by Type: 2012-2019 |
| Latin American Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Latin American Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market Review in Latin America in US$ Million by Application: 2012-2019 |
| Latin American Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| ARGENTINA |
| Argentinean Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027 |
| Cancer Diagnostics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012-2019 |
| Argentinean Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Argentinean Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Argentinean Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| BRAZIL |
| Cancer Diagnostics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Brazilian Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019 |
| Brazilian Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027 |
| Brazilian Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019 |
| Brazilian Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| MEXICO |
| Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| Mexican Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| Mexican Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Mexican Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027 |
| Cancer Diagnostics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012-2019 |
| Rest of Latin America Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Rest of Latin America Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019 |
| Cancer Diagnostics Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 |
| MIDDLE EAST |
| The Middle East Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cancer Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019 |
| The Middle East Cancer Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027 |
| The Middle East Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027 |
| The Middle East Cancer Diagnostics Historic Market by Type in US$ Million: 2012-2019 |
| Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027 |
| The Middle East Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| The Middle East Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| IRAN |
| Iranian Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019 |
| Iranian Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027 |
| Iranian Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Iranian Cancer Diagnostics Market in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 |
| ISRAEL |
| Israeli Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027 |
| Cancer Diagnostics Market in Israel in US$ Million by Type: A Historic Review for the Period 2012-2019 |
| Israeli Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Israeli Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer Diagnostics Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Israeli Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| SAUDI ARABIA |
| Saudi Arabian Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027 |
| Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012-2019 |
| Saudi Arabian Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Saudi Arabian Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Market Review in Saudi Arabia in US$ Million by Application: 2012-2019 |
| Saudi Arabian Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| UNITED ARAB EMIRATES |
| Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| United Arab Emirates Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 |
| United Arab Emirates Cancer Diagnostics Historic Market Analysis in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 |
| REST OF MIDDLE EAST |
| Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027 |
| Rest of Middle East Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019 |
| Rest of Middle East Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| Cancer Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| Rest of Middle East Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cancer Diagnostics Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 |
| AFRICA |
| African Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027 |
| Cancer Diagnostics Market in Africa by Type: A Historic Review in US$ Million for 2012-2019 |
| African Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027 |
| African Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cancer Diagnostics Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019 |
| Cancer Diagnostics Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 25 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com